Becker's Healthcare October 21, 2021
Six deals and acquisitions completed by drugmakers since the end of July, as reported by Becker’s Hospital Review:
- Merck plans to acquire Acceleron Pharma for about $11.5 billion to expand its rare disease drug portfolio.
- Sanofi will acquire New York City-based drugmaker Kadmon for $1.9 billion.
- Pfizer entered into a definitive agreement to buy Canadian cancer...